BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10873238)

  • 1. Peripheral neurotoxic disorders.
    Bromberg MB
    Neurol Clin; 2000 Aug; 18(3):681-94. PubMed ID: 10873238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy.
    Smith EM; Beck SL; Cohen J
    Oncol Nurs Forum; 2008 Jan; 35(1):96-102. PubMed ID: 18192158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Techniques for the neurological examination of taxane-induced neuropathy.
    Ohsumi S; Sunada Y
    Breast Cancer; 2004; 11(1):86-91. PubMed ID: 14718799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic neuropathies.
    Grogan PM; Katz JS
    Neurol Clin; 2005 May; 23(2):377-96. PubMed ID: 15757790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced peripheral neuropathies.
    Prescrire Int; 2013 Sep; 22(141):208-12. PubMed ID: 24171214
    [No Abstract]   [Full Text] [Related]  

  • 6. Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review.
    Smith EML; Kuisell C; Kanzawa-Lee GA; Bridges CM; Alberti P; Cavaletti G; Saad R; Park S;
    Lancet Haematol; 2020 May; 7(5):e408-e417. PubMed ID: 32359452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of neurotoxic injury and cell death.
    McDonald ES; Windebank AJ
    Neurol Clin; 2000 Aug; 18(3):525-40. PubMed ID: 10873229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies.
    Reddy SM; Vergo MT; Paice JA; Kwon N; Helenowski IB; Benson AB; Mulcahy MF; Nimeiri HS; Harden RN
    Clin Colorectal Cancer; 2016 Mar; 15(1):37-46. PubMed ID: 26337211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental considerations of neurotoxic exposures.
    Trask CL; Kosofsky BE
    Neurol Clin; 2000 Aug; 18(3):541-62. PubMed ID: 10873230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic evaluations.
    Donofrio PD
    Neurol Clin; 2000 Aug; 18(3):601-13. PubMed ID: 10873233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical description of toxic neuropathies.
    Little AA; Albers JW
    Handb Clin Neurol; 2015; 131():253-96. PubMed ID: 26563794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.
    McHugh JC; Tryfonopoulos D; Fennelly D; Crown J; Connolly S
    Eur J Cancer Care (Engl); 2012 Nov; 21(6):782-9. PubMed ID: 22594346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of quantitative neurological examination in clinical neurotoxicology.
    Bleecker ML
    Neurol Clin; 2000 Aug; 18(3):563-78. PubMed ID: 10873231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide neurotoxicity: prospective study in patients with lupus erythematosus.
    Briani C; Zara G; Rondinone R; Della Libera S; Ermani M; Ruggero S; Ghirardello A; Zampieri S; Doria A
    Neurology; 2004 Jun; 62(12):2288-90. PubMed ID: 15210897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer.
    Griffith KA; Zhu S; Johantgen M; Kessler MD; Renn C; Beutler AS; Kanwar R; Ambulos N; Cavaletti G; Bruna J; Briani C; Argyriou AA; Kalofonos HP; Yerges-Armstrong LM; Dorsey SG
    J Pain Symptom Manage; 2017 Nov; 54(5):701-706.e1. PubMed ID: 28743660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimizing Risk of Cancer Therapeutics.
    Clark M
    Phys Med Rehabil Clin N Am; 2018 Nov; 29(4):701-719. PubMed ID: 30293625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral Neuropathies Due to Vitamin and Mineral Deficiencies, Toxins, and Medications.
    Staff NP
    Continuum (Minneap Minn); 2020 Oct; 26(5):1280-1298. PubMed ID: 33003002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale.
    Frigeni B; Piatti M; Lanzani F; Alberti P; Villa P; Zanna C; Ceracchi M; Ildebrando M; Cavaletti G
    J Peripher Nerv Syst; 2011 Sep; 16(3):228-36. PubMed ID: 22003937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity?
    Cavaletti G; Alberti P; Marmiroli P
    Am Soc Clin Oncol Educ Book; 2015; ():e553-60. PubMed ID: 25993222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Historical neurotoxins: what we have learned from toxins of the past about diseases of the present.
    Rusyniak DE; Furbee RB; Pascuzzi R
    Neurol Clin; 2005 May; 23(2):337-52. PubMed ID: 15757788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.